ABCELLERA BIOLOGICS INC (ABCL) Stock Analyst Earnings Estimates
NASDAQ:ABCL - Nasdaq - CA00288U1066 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 375.2M 60.89% | 485.4M 29.37% | 38.025M -92.17% | 32.211M -15.29% | 44.214M 37.26% | 66.225M 49.78% | 57.216M -13.60% | 67.016M 17.13% | 78.111M 16.56% | 87.913M 12.55% | 116.28M 32.27% | 129.54M 11.40% | |
| EBITDA YoY % growth | 218.9M 36.13% | 244.4M 11.65% | -212.812M -187.08% | -226.474M -6.42% | -243.02M -7.31% | -246.357M -1.37% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 204.4M 31.03% | 216.5M 5.92% | -237.207M -209.56% | -316.497M -33.43% | -263.534M 16.73% | -240.062M 8.91% | -286.908M -19.51% | -291.389M -1.56% | -292.272M -0.30% | -293.696M -0.49% | -269.28M 8.31% | -265.2M 1.52% | |
| Operating Margin | 54.48% | 44.60% | -623.82% | -982.58% | -596.04% | -362.49% | -501.45% | -434.80% | -374.18% | -334.08% | -231.58% | -204.72% | |
| EPS YoY % growth | 0.47 -23.02% | 0.50 6.38% | -0.52 -204.00% | -0.61 -16.71% | -0.69 -14.05% | -0.62 10.99% | -0.29 53.64% | -0.01 96.43% | 0.35 3,500.00% | 0.56 61.76% | -0.91 -261.82% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 7.75% | -0.18 -27.50% | -0.19 -45.15% | -0.18 -5.00% | -0.18 -17.07% |
| Revenue Q2Q % growth | 7.731M -15.78% | 12.217M 22.73% | 13.292M 81.51% | 12.962M 99.20% | 13.772M 78.14% |
| EBITDA Q2Q % growth | -58.036M -39.32% | -59.378M -18.64% | -58.355M -12.03% | -58.216M -278.57% | -59.194M -1.99% |
| EBIT Q2Q % growth | -68.728M -4.05% | -65.297M -18.95% | -67.034M 28.27% | -64.275M 31.38% | -64.312M 6.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.17 -70.00% | -0.15 | -0.02 | -9.89% |
| Q2 2024 Q2Q % growth | -0.13 -18.18% | -0.15 | 0.02 | 11.08% |
| Q1 2024 Q2Q % growth | -0.14 | -0.17 | 0.03 | 17.44% |
| Q4 2023 Q2Q % growth | -0.17 -70.00% | -0.13 | -0.04 | -26.05% |
| Q3 2023 Q2Q % growth | -0.10 -225.00% | -0.14 | 0.04 | 27.08% |
| Q2 2023 Q2Q % growth | -0.11 -450.00% | -0.13 | 0.02 | 17.04% |
| Q1 2023 Q2Q % growth | -0.14 -125.93% | -0.14 | 0.00 | -1.14% |
| Q4 2022 Q2Q % growth | -0.10 -152.63% | -0.01 | -0.09 | -1,767.41% |
| Q3 2022 Q2Q % growth | 0.08 200.00% | 0.05 | 0.03 | 72.64% |
| Q2 2022 Q2Q % growth | -0.02 -100.00% | -0.02 | 0.00 | -25.93% |
| Q1 2022 Q2Q % growth | 0.54 45.95% | 0.39 | 0.15 | 37.82% |
| Q4 2021 Q2Q % growth | 0.19 -56.82% | 0.19 | 0.00 | -1.35% |
| Q3 2021 Q2Q % growth | -0.08 | -0.05 | -0.03 | -49.39% |
| Q2 2021 Q2Q % growth | -0.01 | 0.08 | -0.09 | -112.61% |
| Q1 2021 Q2Q % growth | 0.37 | 0.39 | -0.02 | -4.10% |
| Q4 2020 Q2Q % growth | 0.44 | 0.62 | -0.18 | -29.28% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 6.507M -1.39% | 8.109M | -1.602M | -19.76% |
| Q2 2024 Q2Q % growth | 7.323M -27.18% | 10.356M | -3.033M | -29.29% |
| Q1 2024 Q2Q % growth | 9.954M -18.36% | 11.052M | -1.098M | -9.93% |
| Q4 2023 Q2Q % growth | 9.179M -57.31% | 9.062M | 117K | 1.29% |
| Q3 2023 Q2Q % growth | 6.599M -93.49% | 12.08M | -5.481M | -45.37% |
| Q2 2023 Q2Q % growth | 10.056M -78.09% | 12.616M | -2.56M | -20.29% |
| Q1 2023 Q2Q % growth | 12.192M -96.15% | 12.351M | -159K | -1.29% |
| Q4 2022 Q2Q % growth | 21.5M -84.57% | 51.817M | -30.317M | -58.51% |
| Q3 2022 Q2Q % growth | 101.4M 1,743.64% | 76.453M | 24.947M | 32.63% |
| Q2 2022 Q2Q % growth | 45.9M 66.30% | 54.661M | -8.761M | -16.03% |
| Q1 2022 Q2Q % growth | 316.6M 56.19% | 224.14M | 92.46M | 41.25% |
| Q4 2021 Q2Q % growth | 139.3M -33.00% | 124.49M | 14.81M | 11.90% |
| Q3 2021 Q2Q % growth | 5.5M -78.22% | 12.848M | -7.348M | -57.19% |
| Q2 2021 Q2Q % growth | 27.6M 146.43% | 72.938M | -45.338M | -62.16% |
| Q1 2021 Q2Q % growth | 202.7M | 200.41M | 2.29M | 1.14% |
| Q4 2020 Q2Q % growth | 207.9M 6,396.88% | 201M | 6.9M | 3.43% |
| Q3 2020 Q2Q % growth | 25.247M 200.23% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -0.63% |
| Revenue | 0% | -2.61% | 0% | -2.46% |